Skip to main content
SRZN logo

Surrozen, Inc.

SRZNNASDAQHealthcareBiotechnology

$27.28Today:- (-)1Y +87.89%

As of Oct 26, 2026 close

Market cap
$631.42M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$11.39$37.83
Volume (live)
-
Avg. volume (3M)
923.73K

Surrozen (SRZN) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Surrozen reported total assets of $98.73M and total liabilities of $286.49M. Shareholders' equity was negative at −$187.76M, meaning liabilities exceed assets. Total debt stood at $6.64M against $89.25M in cash and short-term investments, a net cash position of $82.61M.

Surrozen Balance Sheet Analysis

Values in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Surrozen, Inc. (SRZN) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period endingDec 2025Mar 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Current Assets
Cash and Cash Equivalents89.2534.5734.5736.0424.6933.0934.9829.10
Short-Term Investments0.000.00-0.0051.1568.7614.200.00
Cash & Short-Term Investments89.2534.5734.5736.0475.84101.8549.1829.10
Accounts Receivable0.212.542.542.151.980.000.000.00
Inventory0.000.00-0.000.000.000.000.00
Other Current Assets2.111.831.832.940.763.341.040.31
Total Current Assets91.5638.9338.9341.1381.31105.1950.2229.41
Non-Current Assets
Property, Plant & Equipment (Net)6.438.368.363.866.909.3811.3912.62
Long-Term Investments0.690.00-0.690.0021.660.000.00
Other Non-Current Assets0.731.171.171.091.230.950.440.45
Total Non-Current Assets7.179.549.544.958.1331.9911.8413.07
Total Assets98.7348.4748.4746.0889.44137.1762.0642.49
Current Liabilities
Accounts Payable0.730.310.310.530.662.721.780.97
Short-Term Debt1.291.83-2.502.232.192.111.50
Accrued Liabilities7.62-5.184.136.278.662.98-
Other Current Liabilities0.295.180.190.290.580.593.391.43
Total Current Liabilities9.937.327.327.159.7313.577.283.90
Non-Current Liabilities
Long-Term Debt5.356.646.640.883.385.607.499.20
Other Non-Current Liabilities158.6655.8955.890.120.338.300.000.00
Total Non-Current Liabilities276.5662.5362.531.003.7013.907.499.20
Total Liabilities286.4969.8569.858.1513.4327.4714.7713.10
Stockholders' Equity
Common Stock0.000.00-0.000.000.000.000.00
Retained Earnings-527.29-285.26-285.26-221.70-178.65-142.65-88.00-55.29
Accumulated Other Comprehensive Income0.000.00-0.00-0.24-0.120.000.00
Additional Paid-in Capital339.52263.88263.88259.63254.90252.46135.291.46
Shares Outstanding9.77-3.262.062.012.34--
Total Stockholders' Equity-187.76-21.38-21.3837.9476.00109.7047.2929.39
Total Liabilities & Equity98.7348.4748.4746.0889.44137.1762.0642.49

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Surrozen Balance Sheet

How much debt does Surrozen have?

Surrozen had total debt of $6.64M as of Dec 31, 2025, against $89.25M in cash and short-term investments. Total debt was $8.47M a year earlier.

What are Surrozen's total assets?

Surrozen reported total assets of $98.73M as of Dec 31, 2025, up 103.7% from $48.47M a year earlier. Total liabilities were $286.49M.

What is Surrozen's shareholders' equity?

Surrozen's shareholders' equity was negative at −$187.76M as of Dec 31, 2025, so its liabilities exceeded its assets.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition